Authors:
Chen, XY
Zhong, DF
Xu, HY
Schug, B
Blume, H
Citation: Xy. Chen et al., Simultaneous determination of flupirtine and its major active metabolite in human plasma by liquid chromatography-tandem mass spectrometry, J CHROMAT B, 755(1-2), 2001, pp. 195-202
Authors:
Staab, A
Scheithauer, S
Fieger-Buschges, H
Mutschler, E
Blume, H
Citation: A. Staab et al., A validated high-performance liquid chromatographic assay for the simultaneous determination of denaverine and its N-monodemethyl metabolite in humanplasma, J CHROMAT B, 751(2), 2001, pp. 221-228
Authors:
Blume, H
Bosecke, P
Bourenkov, GP
Kosciesza, D
Bartunik, HD
Citation: H. Blume et al., The protein crystallography beamline BW6 at DORIS - automatic operation and high-throughput data collection, NUCL INST A, 467, 2001, pp. 1358-1362
Citation: A. Bica et al., Determination of clonixin in plasma and urine by reversed-phase high-performance liquid chromatography, J CHROMAT A, 889(1-2), 2000, pp. 135-141
Citation: Xy. Chen et al., Stereoselective pharmacokinetics of propafenone and its major metabolites in healthy Chinese volunteers, EUR J PH SC, 10(1), 2000, pp. 11-16
Authors:
Fieger-Buschges, H
Schussler, G
Larsimont, V
Blume, H
Citation: H. Fieger-buschges et al., Determination of clindamycin in human plasma by high-performance liquid chromatography using coupled columns, J CHROMAT B, 724(2), 1999, pp. 281-286
Authors:
Dingemanse, J
Halabi, A
Kleinbloesem, CH
Heinig, R
Blume, H
Citation: J. Dingemanse et al., Pharmacokinetics and pharmacodynamics of the acetylcholinesterase inhibitor metrifonate in patients with renal impairment, THER DRUG M, 21(3), 1999, pp. 310-316
Authors:
Larsimont, V
Meins, J
Fieger-Buschges, H
Blume, H
Citation: V. Larsimont et al., Validated high-performance liquid chromatographic assay for the determination of promazine in human plasma - Application to pharmacokinetic studies, J CHROMAT B, 719(1-2), 1998, pp. 222-226
Authors:
Wangemann, M
Retzow, A
Evers, G
Mazur, D
Schug, B
Blume, H
Citation: M. Wangemann et al., Bioavailability study of two carbamazepine containing sustained release formulations after multiple oral dose administration, ARZNEI-FOR, 48(12), 1998, pp. 1131-1137